Abstract
(1) Background: Limited studies have utilized nationwide data to assess the patterns of psychiatric practice in other countries. In this study, data from the National Health Insurance Research Database in Taiwan (NHIRD-TW) for 2012 was analyzed to determine the patterns of psychiatric outpatient practice in Taiwan; (2) Methods: To determine the patterns of psychiatric outpatient practice in Taiwan, the data were drawn from the datasets of Taiwan’s National Health Insurance Research Database for 2012, with 619,760 records of outpatient visits representing 1/500 of all the claims in Taiwan for that year. The analysis of psychiatric outpatient visits included patient demographics, diagnoses, and prescribed medications; (3) Results: Neurotic disorders were the most prevalent diagnoses (43.1%, n = 5714). Hypnotics-sedatives and anxiolytics were prescribed in 51.7% (n = 6850) and 39.1% (n = 5181) of psychiatric visits, respectively, with zolpidem being the most commonly prescribed drug (22.6%, n = 2998); and (4) Conclusion: Hypnotics and sedatives were widely prescribed for the outpatient population, and zolpidem had the highest annual prevalence of use. These findings deserve the attention of clinicians and policy makers for monitoring the abuse and dependence of these agents and subsequent adverse events.
Highlights
A Nationwide SurveyYing-Xiu Dai 1,2 , Mu-Hong Chen 2,3 , Tzeng-Ji Chen 1,2 and Ming-Hwai Lin 1,2, *
With ongoing innovations in psychotropic medications, advances in rehabilitation models, and reforms to health care insurance systems, psychiatric practice has changed substantially in recent years
Many studies have investigated the epidemiology of psychiatric visits to emergency departments [4,5,6,7]
Summary
Ying-Xiu Dai 1,2 , Mu-Hong Chen 2,3 , Tzeng-Ji Chen 1,2 and Ming-Hwai Lin 1,2, *. (n = 6850) and 39.1% (n = 5181) of psychiatric visits, respectively, with zolpidem being the most commonly prescribed drug (22.6%, n = 2998); and (4) Conclusion: Hypnotics and sedatives were widely prescribed for the outpatient population, and zolpidem had the highest annual prevalence of use. These findings deserve the attention of clinicians and policy makers for monitoring the abuse and dependence of these agents and subsequent adverse events
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have